Global Microbiome Therapeutics Market Report 2015-2030 - Analysis, Technologies & Forecasts - Key Vendors: 4D Pharma, AbbVie, Human Longevity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Microbiome Therapeutics Market, 2015 - 2030" report to their offering.

The study provides a detailed Microbiome Therapeutics market forecast and opportunity analysis for the short-mid term (2015-2022) and long term (2022-2030). The research, analysis and insights presented in this report include potential sales of FMT therapies and drugs in late stages of development. Our opinions and insights, presented in this study, were influenced by several discussions we conducted with experts in this area.

Currently, there are many popular probiotics, prebiotics, medical food and supplements commercially available in the market as OTC products. These products are known to prevent a number of diseases by restoring the human microbiome to its natural state.

However, these products cannot be used as a replacement for medication or as a treatment for the eradication of the disease. The overall microbiome therapeutics market is still in its infancy with no approved drugs; Faecal microbial transplant (FMT) is the only microbiome related therapy that has entered the market. With several firms and investors displaying a growing interest in this field, the overall market holds a strong potential in the coming years.

Companies Mentioned Include:

  • 4D Pharma
  • AOBiome
  • APC Microbiome Institute
  • AbbVie
  • AgBiome
  • Companion PBx
  • Concorde Medical Group
  • Crohn's and Colitis Foundation of America (CCFA)
  • Hadassah Medical Center
  • Hospital Oberndorf
  • Human Longevity
  • Hy Laboratories
  • INRA National Institute for Agronomic Research
  • Igen Biotech Group
  • Illumina Accelerator
  • Miyarisan Pharmaceutical
  • Morgenthaler
  • SporeGen
  • UAS Labs
  • Universal Stabilisation Technologies

Report Structure:

1. Preface

2. Executive Summary

3. Introduction

4. Microbiome Therapeutics And Diagnostics: Market Landscape

5. Probiotic And Prebiotic Drugs

6. Key Therapeutic Areas

7. Venture Capital Interest

8. Recent Collaborations

9. Market Sizing And Opportunity Analysis

10. Company Profiles

11. Conclusion

12. Interview Transcripts

13. Appendix 1: Tabulated Data

14. Appendix 2: List Of Companies And Organisations

For more information visit http://www.researchandmarkets.com/research/t82wwg/microbiome

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals